Immunotherapy Drugs Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 14895 Report Format: PDF + Excel (Delivery in 48 Hrs)

Immunotherapy Drugs Market Overview

The Global Immunotherapy Drugs Market Size is estimated to reach revenue of $293 billion by 2024, growing at a CAGR of 13.43% during the forecast period 2019-2024. The immunotherapy drugs market growth is characterized by the increasing prevalence of lifestyle diseases across the globe. Also, the increasing adoption of targeted therapies for various diseases is also set to drive the overall market. Immunotherapy is further divided into activation immunotherapies and suppression immunotherapies. Examples of immunotherapy drugs include: granulocyte colony-stimulating factor (G-CSF) and Immunomodulatory imide drugs (IMiDs).

Immunotherapy Drugs Market Report Coverage

The report: “Immunotherapy Drugs Market Forecast (2019-2024)”, by IndustryARC, covers an in-depth analysis of the following segments of the Immunotherapy Drugs Market:

Key Takeaways

·         The North America region is currently dominating the immunotherapy drugs market owing to the larger population affected with various diseases such as cancer. Other major regions are profiled in the final report.

·         The monoclonal antibody has the largest share of the drug type segment. Information about other drug types are provided in the full report.

·         Higher expense of products is considered as a major challenge for this market. Other constraints mentioned in the full report.

Drug Type - Segment Analysis

The monoclonal antibody segment has accounted for the largest share by revenue. This is owing to the increasing amount of funding that is being put into its research as well as its use in the treatment of cancer. People also prefer to use this product for the treatment of cancer as it has minimal side effects. The segment is expected to grow with a CAGR of 7.25% in the forecast period 2019-2024.

Therapy Area – Segment Analysis

By Therapy Area, the Cancer segment has the largest immunotherapy drugs market share by revenue. This is owing to the rise in the prevalence of cancer as well as the rise of the geriatric population. People also favor cancer treatments that have lesser side effects and this can boost the overall growth of the immunotherapy drugs market during the forecast period. The use of immunotherapy can boost the natural killer cells or dendritic cells that is already in the body to fight off the unwanted cancer cells.

 

Geography - Segment Analysis

The North America region currently dominates the overall immunotherapy drugs market with a share of 32% owing to the increasing prevalence of cancer as well as the increasing preference of treatment with minimal side effects. Favorable government initiatives are also expected to boost the market growth in the coming years. However, the APAC region is the fastest growing region. The primary growth factor in the APAC region can be attributed to low manufacturing cost as well as easier regulatory scenario.

Drivers – Immunotherapy Drugs Market

·         Increasing adoption of targeted therapies

There is a global increase in the adoption of targeted therapy. This type of therapy directly targets the causes of cancer such as genes, proteins as well as tissue environment in order to completely treat it. Targeted therapy treats the cancer cells while the normal cells are fine. The increasing adoption of such procedure especially in developed nations is set to boost the overall market for immunotherapy drugs.

·         Supportive Government Policies

Many governmental bodies are creating awareness regarding cancer and other diseases that requires the use of immunotherapy drugs through various initiatives. This can further support the increased usage of immunotherapy drugs and could fuel the overall market growth.

Challenges – Immunotherapy Drugs Market

·         High cost of immunotherapy treatment

Immunotherapy treatment is considered as highly expensive by common people and the availability of other forms of treatment is considered as a major challenge to the growth of the immunotherapy drugs market.

Immunotherapy Drugs Industry Outlook

Expansions and Partnerships are some of the key strategies undertaken by the major players of the Immunotherapy Drugs market. The immunotherapy drugs top 10 companies are: F. Hoffmann-La Roche AG, GlaxoSmithKline, AbbVie, Inc., Amgen, Inc., Merck & Co., Inc., Bristol-Myers Squibb, Novartis International AG, Eli Lilly and Company, Johnson & Johnson, and AstraZeneca plc.

Expansions/Partnerships

Ø  On November 2016, Roche launched imCORE which is a global network of cancer immunotherapy centers of excellence in order to rapidly initiate pre-clinical and clinical research based on latest scientific discoveries.

Ø  On February 2019, GSK and Merck KGaA had announced a global alliance for developing and commercializing M7824 which is a novel immunotherapy that has the potential to treat multiple cancers.

1. Immunotherapy Drugs Market - Overview
        1.1 Definitions and Scope
2. Immunotherapy Drugs Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Immunotherapy Drugs Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Immunotherapy Drugs Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Immunotherapy Drugs Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Immunotherapy Drugs Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Immunotherapy Drugs Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Immunotherapy Drugs Market - By Type of Drug (Market Size -$Million / $Billion)
        8.1 Introduction
        8.2 Monoclonal Antibodies
        8.3 Adult Vaccines
            8.3.1 Preventive Vaccines
            8.3.2 Therapeutic Vaccines
        8.4 Checkpoint Inhibitors
        8.5 Interferons Alpha & Beta
        8.6 Interleukins
        8.7 Other Drugs
9. Immunotherapy Drugs Market - By Therapy Area (Market Size -$Million / $Billion)
        9.1 Introduction
        9.2 Cancer
        9.3 Autoimmune and Inflammatory Diseases
        9.4 Infectious Diseases
        9.5 Other Therapy Areas
10. Immunotherapy Drugs Market - By End User (Market Size -$Million / $Billion)
        10.1 Introduction
        10.2 Hospitals
        10.3 Clinics
        10.4 Other End Users
11. Immunotherapy Drugs- By Geography (Market Size -$Million / $Billion)
        11.1 Immunotherapy Drugs Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                 11.2.5.1 U.S
                 11.2.5.2 Canada
                 11.2.5.3 Mexico
                 11.2.5.4 Rest of North America
        11.3 Immunotherapy Drugs- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                 11.4.5.1 Brazil
                 11.4.5.2 Venezuela
                 11.4.5.3 Argentina
                 11.4.5.4 Ecuador
                 11.4.5.5 Peru
                 11.4.5.6 Colombia
                 11.4.5.7 Costa Rica
                 11.4.5.8 Rest of South America
        11.5 Immunotherapy Drugs- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                 11.6.5.1 U.K
                 11.6.5.2 Germany
                 11.6.5.3 Italy
                 11.6.5.4 France
                 11.6.5.5 Netherlands
                 11.6.5.6 Belgium
                 11.6.5.7 Denmark
                 11.6.5.8 Spain
                 11.6.5.9 Rest of Europe
        11.7 Immunotherapy Drugs - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                 11.8.5.1 China
                 11.8.5.2 Australia
                 11.8.5.3 Japan
                 11.8.5.4 South Korea
                 11.8.5.5 India
                 11.8.5.6 Taiwan
                 11.8.5.7 Malaysia
                 11.8.5.8 Hong kong
                 11.8.5.9 Rest of APAC
        11.9 Immunotherapy Drugs - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                 11.10.5.1 Israel
                 11.10.5.2 Saudi Arabia
                 11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                 11.10.6.1 South Africa
                 11.10.6.2 Rest of Middle East & Africa
12. Immunotherapy Drugs Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Immunotherapy Drugs Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Immunotherapy Drugs Market - Key Company List by Country Premium
15. Immunotherapy Drugs Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Abbvie
        15.3 Amgen Inc
        15.4 Astrazeneca
        15.5 Bristol-Myers Squibb
        15.6 Eli Lilly And Company
        15.7 F. Hoffmann-La Roche Ag
        15.8 Glaxosmithkline Plc
        15.9 Johnson & Johnson
        15.10 Merck & Co , Inc
        15.11 Novartis International Ag
        15.12 Company 11
        15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Immunotherapy Drugs Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Immunotherapy Drugs Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 ($M)
1.1 Monoclonal Antibody Market 2019-2024 ($M) - Global Industry Research
1.2 Adult Vaccine Market 2019-2024 ($M) - Global Industry Research
1.2.1 Preventive Vaccine Market 2019-2024 ($M)
1.2.2 Therapeutic Vaccine Market 2019-2024 ($M)
1.3 Checkpoint Inhibitor Market 2019-2024 ($M) - Global Industry Research
1.4 Interferon Alpha & Beta Market 2019-2024 ($M) - Global Industry Research
1.5 Interleukin Market 2019-2024 ($M) - Global Industry Research
2.Global Immunotherapy Drug Market, By Therapy Area Market 2019-2024 ($M)
2.1 Cancer Market 2019-2024 ($M) - Global Industry Research
2.2 Autoimmune And Inflammatory Disease Market 2019-2024 ($M) - Global Industry Research
2.3 Infectious Disease Market 2019-2024 ($M) - Global Industry Research
3.Global Immunotherapy Drug Market, By End User Market 2019-2024 ($M)
3.1 Hospital Market 2019-2024 ($M) - Global Industry Research
3.2 Clinic Market 2019-2024 ($M) - Global Industry Research
4.Global Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 (Volume/Units)
4.1 Monoclonal Antibody Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Adult Vaccine Market 2019-2024 (Volume/Units) - Global Industry Research
4.2.1 Preventive Vaccine Market 2019-2024 (Volume/Units)
4.2.2 Therapeutic Vaccine Market 2019-2024 (Volume/Units)
4.3 Checkpoint Inhibitor Market 2019-2024 (Volume/Units) - Global Industry Research
4.4 Interferon Alpha & Beta Market 2019-2024 (Volume/Units) - Global Industry Research
4.5 Interleukin Market 2019-2024 (Volume/Units) - Global Industry Research
5.Global Immunotherapy Drug Market, By Therapy Area Market 2019-2024 (Volume/Units)
5.1 Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
5.2 Autoimmune And Inflammatory Disease Market 2019-2024 (Volume/Units) - Global Industry Research
5.3 Infectious Disease Market 2019-2024 (Volume/Units) - Global Industry Research
6.Global Immunotherapy Drug Market, By End User Market 2019-2024 (Volume/Units)
6.1 Hospital Market 2019-2024 (Volume/Units) - Global Industry Research
6.2 Clinic Market 2019-2024 (Volume/Units) - Global Industry Research
7.North America Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 ($M)
7.1 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
7.2 Adult Vaccine Market 2019-2024 ($M) - Regional Industry Research
7.2.1 Preventive Vaccine Market 2019-2024 ($M)
7.2.2 Therapeutic Vaccine Market 2019-2024 ($M)
7.3 Checkpoint Inhibitor Market 2019-2024 ($M) - Regional Industry Research
7.4 Interferon Alpha & Beta Market 2019-2024 ($M) - Regional Industry Research
7.5 Interleukin Market 2019-2024 ($M) - Regional Industry Research
8.North America Immunotherapy Drug Market, By Therapy Area Market 2019-2024 ($M)
8.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
8.2 Autoimmune And Inflammatory Disease Market 2019-2024 ($M) - Regional Industry Research
8.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
9.North America Immunotherapy Drug Market, By End User Market 2019-2024 ($M)
9.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
9.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
10.South America Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 ($M)
10.1 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
10.2 Adult Vaccine Market 2019-2024 ($M) - Regional Industry Research
10.2.1 Preventive Vaccine Market 2019-2024 ($M)
10.2.2 Therapeutic Vaccine Market 2019-2024 ($M)
10.3 Checkpoint Inhibitor Market 2019-2024 ($M) - Regional Industry Research
10.4 Interferon Alpha & Beta Market 2019-2024 ($M) - Regional Industry Research
10.5 Interleukin Market 2019-2024 ($M) - Regional Industry Research
11.South America Immunotherapy Drug Market, By Therapy Area Market 2019-2024 ($M)
11.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
11.2 Autoimmune And Inflammatory Disease Market 2019-2024 ($M) - Regional Industry Research
11.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
12.South America Immunotherapy Drug Market, By End User Market 2019-2024 ($M)
12.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
12.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
13.Europe Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 ($M)
13.1 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
13.2 Adult Vaccine Market 2019-2024 ($M) - Regional Industry Research
13.2.1 Preventive Vaccine Market 2019-2024 ($M)
13.2.2 Therapeutic Vaccine Market 2019-2024 ($M)
13.3 Checkpoint Inhibitor Market 2019-2024 ($M) - Regional Industry Research
13.4 Interferon Alpha & Beta Market 2019-2024 ($M) - Regional Industry Research
13.5 Interleukin Market 2019-2024 ($M) - Regional Industry Research
14.Europe Immunotherapy Drug Market, By Therapy Area Market 2019-2024 ($M)
14.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
14.2 Autoimmune And Inflammatory Disease Market 2019-2024 ($M) - Regional Industry Research
14.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
15.Europe Immunotherapy Drug Market, By End User Market 2019-2024 ($M)
15.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
15.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
16.APAC Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 ($M)
16.1 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
16.2 Adult Vaccine Market 2019-2024 ($M) - Regional Industry Research
16.2.1 Preventive Vaccine Market 2019-2024 ($M)
16.2.2 Therapeutic Vaccine Market 2019-2024 ($M)
16.3 Checkpoint Inhibitor Market 2019-2024 ($M) - Regional Industry Research
16.4 Interferon Alpha & Beta Market 2019-2024 ($M) - Regional Industry Research
16.5 Interleukin Market 2019-2024 ($M) - Regional Industry Research
17.APAC Immunotherapy Drug Market, By Therapy Area Market 2019-2024 ($M)
17.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
17.2 Autoimmune And Inflammatory Disease Market 2019-2024 ($M) - Regional Industry Research
17.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
18.APAC Immunotherapy Drug Market, By End User Market 2019-2024 ($M)
18.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
18.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
19.MENA Immunotherapy Drug Market, By Type Of Drug Market 2019-2024 ($M)
19.1 Monoclonal Antibody Market 2019-2024 ($M) - Regional Industry Research
19.2 Adult Vaccine Market 2019-2024 ($M) - Regional Industry Research
19.2.1 Preventive Vaccine Market 2019-2024 ($M)
19.2.2 Therapeutic Vaccine Market 2019-2024 ($M)
19.3 Checkpoint Inhibitor Market 2019-2024 ($M) - Regional Industry Research
19.4 Interferon Alpha & Beta Market 2019-2024 ($M) - Regional Industry Research
19.5 Interleukin Market 2019-2024 ($M) - Regional Industry Research
20.MENA Immunotherapy Drug Market, By Therapy Area Market 2019-2024 ($M)
20.1 Cancer Market 2019-2024 ($M) - Regional Industry Research
20.2 Autoimmune And Inflammatory Disease Market 2019-2024 ($M) - Regional Industry Research
20.3 Infectious Disease Market 2019-2024 ($M) - Regional Industry Research
21.MENA Immunotherapy Drug Market, By End User Market 2019-2024 ($M)
21.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
21.2 Clinic Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
2.Canada Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
3.Mexico Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
4.Brazil Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
5.Argentina Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
6.Peru Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
7.Colombia Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
8.Chile Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
9.Rest of South America Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
10.UK Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
11.Germany Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
12.France Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
13.Italy Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
14.Spain Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
15.Rest of Europe Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
16.China Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
17.India Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
18.Japan Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
19.South Korea Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
20.South Africa Immunotherapy Drugs Market Revenue, 2019-2024 ($M)
21.North America Immunotherapy Drugs By Application
22.South America Immunotherapy Drugs By Application
23.Europe Immunotherapy Drugs By Application
24.APAC Immunotherapy Drugs By Application
25.MENA Immunotherapy Drugs By Application
26.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Merck & Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Novartis International Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Johnson & Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Amgen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Abbvie, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Bristol-Myers Squibb, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)